Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen

被引:54
|
作者
Apt, D
Raviprakash, K
Brinkman, A
Semyonov, A
Yang, SM
Skinner, C
Diehl, L
Lyons, R
Porter, K
Punnonen, J
机构
[1] Maxygen Inc, Human Therapeut, Redwood City, CA 94063 USA
[2] USN, Med Res Ctr, Viral Dis Dept, Silver Spring, MD 20910 USA
[3] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA
关键词
dengue virus; antigen; tetravalent; multivalent antigen; DNA shuffling; cross-neutralizing antibodies;
D O I
10.1016/j.vaccine.2005.07.100
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We employed DNA shuffling and screening technologies to develop a single recombinant dengue envelope (E) antigen capable of inducing neutralizing antibodies against all four antigenically distinct dengue serotypes. By DNA shuffling of codon-optimized dengue 1-4 E genes, we created a panel of novel chimeric clones expressing C-terminal truncated E antigens that combined epitopes from all four dengue serotypes. DNA vaccines encoding these novel chimeras induced multivalent T cell and neutralizing antibody responses against all four dengue serotypes in mice. By contrast, a mixture of four unshuffled, parental DNA vaccines failed to produce tetravalent neutralizing antibodies in mice. length neutralizing antibody titers for some of these antigens could be further improved by extending the sequences to express full membrane and envelope proteins. The chimeric antigens also protected mice against a lethal dengue-2 virus challenge. These data demonstrate that DNA shuffling and associated screening can lead to the selection of multi-epitope antigens against closely related dengue virus serotypes and suggest a broad utility for these technologies in optimizing vaccine antigens. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:335 / 344
页数:10
相关论文
共 50 条
  • [31] A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates
    Hsin-Wei Chen
    Shih-Jen Liu
    Yi-Shiuan Li
    Hsueh-Hung Liu
    Jy-Ping Tsai
    Chen-Yi Chiang
    Mei-Yu Chen
    Chyi-Sing Hwang
    Chin-Cheng Huang
    Hui-Mei Hu
    Han-Hsuan Chung
    Sze-Hsien Wu
    Pele Chong
    Chih-Hsiang Leng
    Chien-Hsiung Pan
    Archives of Virology, 2013, 158 : 1523 - 1531
  • [32] Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort
    Katzelnick, Leah C.
    Montoya, Magelda
    Gresh, Lionel
    Balmaseda, Angel
    Harris, Eva
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (03) : 728 - 733
  • [33] A human monoclonal antibody to neutralize all four serotypes of dengue virus derived from patients at the convalescent phase of infection
    Lu, Jiansheng
    Chen, Lei
    Du, Peng
    Guo, Jiazheng
    Wang, Xi
    Jiang, Yujia
    Yu, Yunzhou
    Wang, Rong
    Yang, Zhixin
    VIROLOGY, 2022, 576 : 74 - 82
  • [34] Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes
    Ito, Mikako
    Katakai, Yuko
    Ono, Fumiko
    Akari, Hirofumi
    Mukai, Ryo-zabro
    Takasaki, Tomohiko
    Kotaki, Akira
    Kurane, Ichiro
    ARCHIVES OF VIROLOGY, 2011, 156 (06) : 1073 - 1077
  • [35] Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes
    Mikako Ito
    Yuko Katakai
    Fumiko Ono
    Hirofumi Akari
    Ryo-zabro Mukai
    Tomohiko Takasaki
    Akira Kotaki
    Ichiro Kurane
    Archives of Virology, 2011, 156 : 1073 - 1077
  • [36] Limited cross-reactivity of mouse monoclonal antibodies against Dengue virus capsid protein among four serotypes
    Noda, Megumi
    Masrinoul, Promsin
    Punkum, Chaweewan
    Pipattanaboon, Chonlatip
    Ramasoota, Pongrama
    Setthapramote, Chayanee
    Sasaki, Tadahiro
    Sasayama, Mikiko
    Yamashita, Akifumi
    Kurosu, Takeshi
    Ikuta, Kazuyoshi
    Okabayashi, Tamaki
    BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 409 - 416
  • [37] Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity
    Park, Jisang
    Lee, Hyun-Young
    Ly Tuan Khai
    Nguyen Thi Thu Thuy
    Le Quynh Mai
    Jang, Yong-Suk
    VACCINES, 2020, 8 (01)
  • [38] Magnitude and Functionality of the NS1-Specific Antibody Response Elicited by a Live-Attenuated Tetravalent Dengue Vaccine Candidate
    Sharma, Mayuri
    Glasner, Dustin R.
    Watkins, Heather
    Puerta-Guardo, Henry
    Kassa, Yoseph
    Egan, Michael A.
    Dean, Hansi
    Harris, Eva
    JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (06): : 867 - 877
  • [39] An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity
    Khanam, Saima
    Pilankatta, Rajendra
    Khanna, Navin
    Swaminathan, Sathyamangalam
    VACCINE, 2009, 27 (43) : 6011 - 6021
  • [40] The Specificity of the Persistent IgM Neutralizing Antibody Response in Zika Virus Infections among Individuals with Prior Dengue Virus Exposure
    Calvert, Amanda E.
    Horiuchi, Kalanthe
    Boroughs, Karen L.
    Ong, Yee T.
    Anderson, Kimberly M.
    Biggerstaff, Brad J.
    Stone, Mars
    Simmons, Graham
    Busch, Michael P.
    Huang, Claire Y-H
    JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (08)